Accumulation of triosephosphate isomerase, with sequence homology to β amyloid peptides, in vessel walls of the newborn piglet hippocampus

Microscopy Research and Technique

Volumn 70, Issue 7, 2007, Pages 648-655

  Kusaka, Takashi ^a   Ueno, Masaki ^a   Miki, Takanori ^a   Kanenishi, Kenji ^a   Nagai, Yukiko ^b   Huang, Cheng Long ^a   Okamoto, Yasuo ^a   Ogawa, Takafumi ^a   Onodera, Masayuki ^c   Itoh, Susumu ^a   Akiguchi, Ichiro ^d   Sakamoto, Haruhiko ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d Center for Cerebrovascular Disease   (Japan)

Author keywords

Glycolysis; Hippocampus; Piglet; Triosephosphate isomerase; amyloid

Indexed keywords

DESORPTION; GLYCOPROTEINS; MASS SPECTROMETRY;

AMYLOID PEPTIDES; GLYCOLYSIS; HIPPOCAMPUS; IMMUNOREACTIVITIES; NEWBORN PIGLET; PIGLET; SEQUENCE HOMOLOGY; TRIOSEPHOSPHATE ISOMERASE; WESTERN-BLOTTING; Β-AMYLOID;

PEPTIDES;

AMYLOID BETA PROTEIN[25-35]; AMYLOID PRECURSOR PROTEIN; TRIOSEPHOSPHATE ISOMERASE; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME ASSAY; HIPPOCAMPUS; IMMUNOREACTIVITY; MACROPHAGE ACTIVATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROGLIA; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; NEWBORN; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; WESTERN BLOTTING;

EID: 34447275474     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.20448     Document Type: Article

References (36)

1. Attems J, Lintner F, Jellinger KA. 2004. Amyloid β peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol 107:283-291.
2. Baron JC. 1998. Démences et troubles de la mémoire d'origine dégénérative-Apport de l'imagerie fonctionnelle. Rev Neurol 154:122-130.
3. Bigl M, Eschrich K. 1995. Interaction of rat brain phosphofructokinase with Alzheimer's βA4-amyloid. Neurochem Int 26:69-75.
4. Bigl M, Beck M, Bleyl AD, Bigl V, Eschrich K. 1999. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J Neural Transm 106:499-511.
5. Bonnet R, Pavlovic S, Lehmann J, Rommelspacher H. 2004. The strong inhibition of triosephosphate isomerase by the natural β-carbolines may explain their neurotoxic actions. Neuroscience 127: 443-453.
6. Chou DKH, Zhang J, Smith FI, McCaffery P, Jungalwala FB. 2004. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration. J Neurochem 10:1389-1401.
7. Contreras CF, Canales MA, Alvarez A, De Ferrari GV, Inestrosa NC. 1999. Molecular modeling of the amyloid-β-peptide using the homology to a fragment of triosephosphate isomerase that forms amyloid in vitro. Protein Eng 12:959-966.
8. Cumming RC, Schubert D. 2005. Amyloid-β induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J 19:2060-2062.
9. Graeber MB, Streit WJ, Kreutzberg GW. 1989. Identity of ED2-positive perivascular cells in rat brain. J Neurosci Res 22:103-106.
10. Graeber MB, Streit WJ, Buringer D, Sparks DL, Kreutzberg GW. 1992. Ultrastructural location of major histocompatibility complex (MHC) class II positive perivascular cells in histologically normal human brain. J Neuropathol Exp Neurol 51:303-311.
11. Guillemin GJ, Brew BJ. 2004. Microglia, macrophage, perivascular macrophages, and pericytes: A review of function and identification. J Leukoc Biol 75:388-397.
12. Harr SD, Simonian NA, Hyman BT. 1995. Functional alterations in Alzheimer's disease: Decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. J Neuropathol Exp Neurol 54:38-41.
13. Hickey WF, Kimura H. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290-292.
14. Ishimaru H, Ishikawa K, Haga S, Shoji M, Ohe Y, Haga C, Sasaki A, Takahashi A, Maruyama Y. 1996. Accumulation of apolipoprotein E and β-amyloid-like protein in a trace of the hippocampal cell layer after ischaemic delayed neuronal death. Neuroreport 7:3063-3067.
15. Iwatsubo T, Okada A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. 1994. Visualization of Aβ42(43) and Ap40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 13:45-53.
16. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. 2001. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21:372-381.
17. Kristensen DB, Imamura K, Miyamoto Y, Yoshizato K. 2000. Mass spectrometric approaches for the characterization of proteins on a hybrid quadrupole time-of-flight (Q-TOF) mass spectrometer. Electrophoresis 21:430-439.
18. Kusaka T, Matsuura S, Fujikawa Y, Okubo K, Kawada K, Namba M, Okada H, Imai T, Isobe K, Itoh S. 2004. Relationship between cerebral interstitial levels of amino acids and phsphorylation potential during secondary energy failure in hypoxic-ischemic newborn piglets. Pediatr Res 55:273-279.
19. Mato M, Ookawara S, Sakamoto A, Aikawa E, Ogawa T, Mitsuhashi U, Masuzawa T, Suzuki H, Honda M, Yazaki Y, Watanabe E, Luoma J, Yla-Herttuala S, Fraser I, Gordon S, Kodama T. 1996. Involvement of specific macrophage-lineage cells surrounding arterioles in barrier and scavenger function in brain cortex. Proc Natl Acad Sci USA 92:3269-3274.
20. 2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. J Clin Invest 98:1088-1094.
21. Mooradian AD, Chung HC, Shah GN. 1997. GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol Aging 18:469-474.
22. Oyama R, Yamamoto H, Titani K. 2000. Glutamine synthetase, hemoglobin α-chain, and macrophage migration inhibitory factor binding to amyloid β-protein: Their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation. Biochim Biophys Acta 1479:91-102.
23. Pardridge WM, Vinters HV, Miller BL, Tourtellotte WW, Eisenberg JB, Yang J. 1987. High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin G. Biochem Biophys Res Commun 145:241-248.
24. Poon HF, Castegna A, Farr SA, Thongboonkerd V, Lynn BC, Banks WA, Morley JE, Klein JB, Butterfield DA. 2004. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated- prone 8 mice brain. Neuroscience 126:915-926.
25. Popa-Wagner A, Schroder E, Walker LC, Kessler C. 1998. β-amyloid precursor protein and β-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion. Effect of age. Stroke 29:2196-2202.
26. Schubert D. 2005. Glucose metabolism and Alzheimer's disease. Ageing Res Rev 4:240-257.
27. Schulze H, Schuler A, Stuber D, Dobeli H, Langen H, Huber G. 1993. Rat brain glyceraldehydes-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's β-amyloid precursor protein. J Neurochem 60:1915-1922.
28. Shevchenko A, Wilm M, Vorm O, Mann M. 1996. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 68:850-858.
29. Shohami E, Ginis I, Hallenbeck JM. 1999. Dual role of tumor necrosis factor α in brain injury. Cytokine Growth Factor Rev 10:119-130.
30. Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P. 1994. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol 35:546-551.
31. Stern RA, Trojanowski JQ, Lee VM-Y. 1990. Antibodies to the β-amyloid peptide cross-react with conformational epitopes in human fibrinogen subunits from peripheral blood. FEBS Lett 264:43-47.
32. Sunaga K, Takahashi H, Chuang DM, Ishitani R. 1995. Glyceraldehyde-3- phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain. Neurosci Lett 200:133-136.
33. Tamaoka A, Endoh R, Shoji S, Takahashi H, Hirokawa K, Teplow DB, Selkoe DJ, Mori H. 1996. Antibodies to amyloid β protein (A β) crossreact with glyceraldehydes-3-phosphate dehydrogenase (GADPH). Neurobiol Aging 17:405-414.
34. Van Groen T, Puurunen K, Maki H-M, Sivenius J, Jolkkonen J. 2005. Transformation of diffuse β-amyloid precursor protein and β-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke 36:1551-1556.
35. Vannucci RC, Vannucci SJ. 2004. Perinatal brain metabolism. In: Polin RA, Fox WW, Abman SH, editors. Fetal and neonatal physiology, Vol 2. Pennsylvania: Saunders, pp. 1713-1725.
36. Yamaji R, Fujita K, Nakanishi I, Nagao K, Naito M, Tsuruo T, Inui H, Nakano Y. 2004. Hypoxic up-regulation of triosephosphate isomerase expression in mouse brain capillary endothelial cells. Arch Biochem Biophys 423:332-342.